Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FUANV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,173
Award facts
- Contract value 100% obligated
- $9,173.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $9,173.49. This firm fixed-price delivery order, with an ultimate completion date of October 30, 2025, represents a pediatric commitment under a larger indefinite delivery contract (IDC) vehicle. The award was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Jardiance is a prescription medication used to manage type 2 diabetes, reflecting the company's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's prime IDC with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support contract valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a key vendor for the Defense Health Agency and other federal healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's federal contract award history demonstrates consistent capability to meet DLA requirements through competitive procurement and timely delivery of critical healthcare commodities supporting military operations and veteran care worldwide.
Quick answers
Who was awarded contract SPE2DB26FUANV?
SPE2DB26FUANV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FUANV worth?
The government has obligated $9,173 on SPE2DB26FUANV.
Is contract SPE2DB26FUANV an order under another contract?
Yes. SPE2DB26FUANV is a delivery order under SPE2DB25D3306, an indefinite delivery contract.
Was contract SPE2DB26FUANV competed?
The extent of competition for SPE2DB26FUANV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award